Table 3 Susceptibilities of P.aeruginosa to various antibiotics and the concordance and kappa statistics between CLSI 2015 and EUCAST 2015 guidelines
CLSI (%); n = 532 | EUCAST (%); n = 532 | Concordance (%) | Kappa, κ (95 % CI) | |||||
|---|---|---|---|---|---|---|---|---|
S | I | R | S | I | R | |||
Amikacin | 79.5 | 3.0 | 17.5 | 72.2 | 7.3 | 20.5 | 89.7 | 0.734 (0.703; 0.765) |
Ceftazidime | 70.9 | 4.7 | 24.4 | 70.9 | 0 | 29.1 | 95.3 | 0.890 (0.870; 0.910) |
Cefepime | 72.6 | 4.7 | 22.7 | 72.6 | 0 | 27.4 | 95.3 | 0.886 (0.866; 0.906) |
Gentamicin | 72.6 | 6.2 | 21.2 | 72.6 | 0 | 27.4 | 93.8 | 0.851 (0.829; 0.873) |
Meropenem | 64.1 | 8.3 | 27.6 | 64.1 | 12.8 | 23.1 | 95.5 | 0.912 (0.895; 0.929) |
Pip-taz | 64.5 | 8.3 | 27.3 | 64.5 | 0 | 35.5 | 91.7 | 0.830 (0.808; 0.852) |
Ciprofloxacin | 71.8 | 5.3 | 22.9 | 66.2 | 5.6 | 28.2 | 89.1 | 0.762 (0.736; 0.788) |